STAAR Surgical Activist Shareholder Broadwood Reiterates Demand for Board Shake-Up Ahead of Alcon Merger Vote

Broadwood Partners, a shareholder with a 30.2% stake in STAAR Surgical, is pushing to remove three members from the company's board ahead of the Dec. 19 merger vote with Alcon AG. Broadwood argues that Chairwoman Elizabeth Yeu, CEO Stephen Farrell, and Compensation Committee Chair Art Butcher mishandled the merger process and compromised confidence in the board's oversight. STAAR has defended its conduct, saying Yeu's prior consulting work with Alcon was disclosed and reviewed by the board, and the executive compensation packages are customary and aligned with shareholder value maximization.